Pfizer Inc.
PFE
株式のランク
#121
Pfizer Inc. is a global biopharmaceutical leader engaged in the research,... Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
株価
$29.55
最終同期: 2026-10-16
時価総額
$168.40B
変化（1日）
0.37%
変化（1年）
20.54%
国
US
取引 Pfizer Inc. (PFE)
カテゴリー
Healthcare
Pfizer Inc.（PFE）の営業利益率
October 2026 時点の営業利益率 TTM: 25.08%
Pfizer Inc. の最新の財務報告と株価によると、現在の営業利益率（TTM）は 25.08% です。2024 年末時点では 25.91% でした。
Pfizer Inc. の営業利益率の履歴（2000 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 25.08% | 1.66% |
| 2025 | 24.67% | -4.79% |
| 2024 | 25.91% | 191.45% |
| 2023 | 8.89% | -76.25% |
| 2022 | 37.43% | 46.33% |
| 2021 | 25.58% | 17.29% |
| 2020 | 21.81% | 19.57% |
| 2019 | 18.24% | -36.00% |
| 2018 | 28.50% | 4.05% |
| 2017 | 27.39% | 1.37% |
| 2016 | 27.02% | -0.73% |
| 2015 | 27.22% | -3.75% |
| 2014 | 28.28% | -13.62% |
| 2013 | 32.74% | -0.79% |
| 2012 | 33.00% | 9.56% |
| 2011 | 30.12% | 13.92% |
| 2010 | 26.44% | -17.40% |
| 2009 | 32.01% | -7.00% |
| 2008 | 34.42% | 19.72% |
| 2007 | 28.75% | -7.85% |
| 2006 | 31.20% | 1.79% |
| 2005 | 30.65% | -5.81% |
| 2004 | 32.54% | 36.15% |
| 2003 | 23.90% | -36.99% |
| 2002 | 37.93% | 11.49% |
| 2001 | 34.02% | 16.03% |
| 2000 | 29.32% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 49.72% | -98.02% |
US
|
|
| 25.70% | -98.98% |
US
|
|
| 29.32% | -98.83% |
US
|
|
| 26.59% | -98.94% |
CH
|
|
| 16.65% | -99.34% |
US
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。